Uso de cannabis sativa no tratamento da doença de Parkinson

Detalhes bibliográficos
Autor(a) principal: Santos, Anny Rosielly Sousa
Data de Publicação: 2023
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Institucional da UFS
Texto Completo: https://ri.ufs.br/jspui/handle/riufs/19330
Resumo: Parkinson's disease (DP), which has affected more than 1% of elderly people over 60 years of age, is characterized by signs such as bradykinesia, tremor at rest, muscle rigidity and postural instability. These symptoms are the result of the degeneration of dopamine-producing neurons, therefore, the basis of PD treatment is the use of medications that increase brain concentrations of dopamine or directly stimulate dopamine receptors. Another option for drug therapy is the use of cannabinoids. Cannabis sativa has attracted the attention of researchers and health professionals, as several patients report that, after using these cannabinoids, motor and non-motor problems are being controlled and consequently there is an improvement in quality of life. Therefore, the objective of the present study is to review how the use of cannabis sativa can improve the signs and symptoms reported by patients suffering from this disorder. A bibliographical review was carried out, with an exploratory characteristic and a qualitative approach, selecting the articles that were most relevant in relation to the topic addressed. It was realized that the pharmacological effects of phytocannabinoids, substances extracted from cannabis sativa and which interact with the endocannabinoid system, are the result of interactions between these chemical compounds and the CB1 and CB2 cannabinoid receptors. When evaluating the scientific articles that made up this review, it was possible to see that substances derived from cannabis sativa, mainly tetrahydrocannabinol and cannabidiol, when administered together and in small doses are effective in the treatment of PD, in addition, most patients with this disorder were in favor of the medicinal use of cannabis sativa.
id UFS-2_2abbb913884e1a7764e19a0b5a094e55
oai_identifier_str oai:ufs.br:riufs/19330
network_acronym_str UFS-2
network_name_str Repositório Institucional da UFS
repository_id_str
spelling Santos, Anny Rosielly SousaDi Pietro, Giuliano2024-03-25T13:08:31Z2024-03-25T13:08:31Z2023-09-21Santos, Anny Rosielly Sousa. Uso de cannabis sativa no tratamento da doença de Parkinson. São Cristóvão, 2023. Monografia (graduação em Farmácia) – Departamento de Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Sergipe, São Cristóvão, SE, 2023https://ri.ufs.br/jspui/handle/riufs/19330Parkinson's disease (DP), which has affected more than 1% of elderly people over 60 years of age, is characterized by signs such as bradykinesia, tremor at rest, muscle rigidity and postural instability. These symptoms are the result of the degeneration of dopamine-producing neurons, therefore, the basis of PD treatment is the use of medications that increase brain concentrations of dopamine or directly stimulate dopamine receptors. Another option for drug therapy is the use of cannabinoids. Cannabis sativa has attracted the attention of researchers and health professionals, as several patients report that, after using these cannabinoids, motor and non-motor problems are being controlled and consequently there is an improvement in quality of life. Therefore, the objective of the present study is to review how the use of cannabis sativa can improve the signs and symptoms reported by patients suffering from this disorder. A bibliographical review was carried out, with an exploratory characteristic and a qualitative approach, selecting the articles that were most relevant in relation to the topic addressed. It was realized that the pharmacological effects of phytocannabinoids, substances extracted from cannabis sativa and which interact with the endocannabinoid system, are the result of interactions between these chemical compounds and the CB1 and CB2 cannabinoid receptors. When evaluating the scientific articles that made up this review, it was possible to see that substances derived from cannabis sativa, mainly tetrahydrocannabinol and cannabidiol, when administered together and in small doses are effective in the treatment of PD, in addition, most patients with this disorder were in favor of the medicinal use of cannabis sativa.A Doença de Parkinson (DP) que tem afetado mais de 1% dos idosos acima de 60 anos é caracterizada por apresentar sinais como bradicinesia, tremor em repouso, rigidez muscular e instabilidade postural. Esses sintomas são resultado da degeneração dos neurônios produtores de dopamina, por isso, a base do tratamento da DP é o uso de medicamentos que aumentam as concentrações cerebrais de dopamina ou estimulam diretamente os receptores da mesma. Uma outra opção de terapia medicamentosa é o uso de canabinoides. A cannabis sativa tem chamado atenção de pesquisadores e profissionais da saúde, visto que diversos pacientes relatam que, após o uso desses canabinoides, os problemas motores e não motores estão sendo controlados e consequentemente há uma melhora na qualidade de vida. Sendo assim, o objetivo do presente estudo é fazer uma revisão sobre como o uso da cannabis sativa pode melhorar os sinais e sintomas relatados pelos pacientes que sofrem desse distúrbio. Foi realizada uma revisão bibliográfica, com característica exploratória e abordagem qualitativa, selecionando os artigos que tivessem maior relevância em relação ao tema abordado. Percebeu-se que os efeitos farmacológicos dos fitocanabinoides, substâncias extraídas da cannabis sativa e que interagem com o sistema endocanabinoide, são resultado de interações entre esses compostos químicos e os receptores canabinoides CB1 e CB2. Ao avaliar os artigos científicos que compuseram essa revisão foi possível perceber que as substâncias derivadas da cannabis sativa, principalmente o tetrahidrocanabinol e o canabidiol, quando administradas em conjunto e em pequenas doses apresentam efetividade no tratamento da DP, além disso a maior parte dos pacientes com esse distúrbio se mostraram a favor do uso medicinal da cannabis sativa.São Cristóvão, SEporFarmáciaCannabis medicinalFitocanabinoidesCanabidiolDoença de ParkinsonMedicinal cannabisPhytocannabinoidsCannabidiolTetrahydrocannabinolCIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL::BIODISPONIBILIDADEUso de cannabis sativa no tratamento da doença de Parkinsoninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal de Sergipe (UFS)DFA - Departamento de Farmácia – São Cristóvão - Presencialreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81475https://ri.ufs.br/jspui/bitstream/riufs/19330/1/license.txt098cbbf65c2c15e1fb2e49c5d306a44cMD51ORIGINALAnny_Rosielly_Sousa_Santos.pdfAnny_Rosielly_Sousa_Santos.pdfapplication/pdf949798https://ri.ufs.br/jspui/bitstream/riufs/19330/2/Anny_Rosielly_Sousa_Santos.pdf07c8edf96623d9b3b45dcc7e835bdd07MD52riufs/193302024-03-25 10:09:41.979oai:ufs.br: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Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2024-03-25T13:09:41Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false
dc.title.pt_BR.fl_str_mv Uso de cannabis sativa no tratamento da doença de Parkinson
title Uso de cannabis sativa no tratamento da doença de Parkinson
spellingShingle Uso de cannabis sativa no tratamento da doença de Parkinson
Santos, Anny Rosielly Sousa
Farmácia
Cannabis medicinal
Fitocanabinoides
Canabidiol
Doença de Parkinson
Medicinal cannabis
Phytocannabinoids
Cannabidiol
Tetrahydrocannabinol
CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL::BIODISPONIBILIDADE
title_short Uso de cannabis sativa no tratamento da doença de Parkinson
title_full Uso de cannabis sativa no tratamento da doença de Parkinson
title_fullStr Uso de cannabis sativa no tratamento da doença de Parkinson
title_full_unstemmed Uso de cannabis sativa no tratamento da doença de Parkinson
title_sort Uso de cannabis sativa no tratamento da doença de Parkinson
author Santos, Anny Rosielly Sousa
author_facet Santos, Anny Rosielly Sousa
author_role author
dc.contributor.author.fl_str_mv Santos, Anny Rosielly Sousa
dc.contributor.advisor1.fl_str_mv Di Pietro, Giuliano
contributor_str_mv Di Pietro, Giuliano
dc.subject.por.fl_str_mv Farmácia
Cannabis medicinal
Fitocanabinoides
Canabidiol
Doença de Parkinson
topic Farmácia
Cannabis medicinal
Fitocanabinoides
Canabidiol
Doença de Parkinson
Medicinal cannabis
Phytocannabinoids
Cannabidiol
Tetrahydrocannabinol
CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL::BIODISPONIBILIDADE
dc.subject.eng.fl_str_mv Medicinal cannabis
Phytocannabinoids
Cannabidiol
Tetrahydrocannabinol
dc.subject.cnpq.fl_str_mv CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL::BIODISPONIBILIDADE
description Parkinson's disease (DP), which has affected more than 1% of elderly people over 60 years of age, is characterized by signs such as bradykinesia, tremor at rest, muscle rigidity and postural instability. These symptoms are the result of the degeneration of dopamine-producing neurons, therefore, the basis of PD treatment is the use of medications that increase brain concentrations of dopamine or directly stimulate dopamine receptors. Another option for drug therapy is the use of cannabinoids. Cannabis sativa has attracted the attention of researchers and health professionals, as several patients report that, after using these cannabinoids, motor and non-motor problems are being controlled and consequently there is an improvement in quality of life. Therefore, the objective of the present study is to review how the use of cannabis sativa can improve the signs and symptoms reported by patients suffering from this disorder. A bibliographical review was carried out, with an exploratory characteristic and a qualitative approach, selecting the articles that were most relevant in relation to the topic addressed. It was realized that the pharmacological effects of phytocannabinoids, substances extracted from cannabis sativa and which interact with the endocannabinoid system, are the result of interactions between these chemical compounds and the CB1 and CB2 cannabinoid receptors. When evaluating the scientific articles that made up this review, it was possible to see that substances derived from cannabis sativa, mainly tetrahydrocannabinol and cannabidiol, when administered together and in small doses are effective in the treatment of PD, in addition, most patients with this disorder were in favor of the medicinal use of cannabis sativa.
publishDate 2023
dc.date.issued.fl_str_mv 2023-09-21
dc.date.accessioned.fl_str_mv 2024-03-25T13:08:31Z
dc.date.available.fl_str_mv 2024-03-25T13:08:31Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Santos, Anny Rosielly Sousa. Uso de cannabis sativa no tratamento da doença de Parkinson. São Cristóvão, 2023. Monografia (graduação em Farmácia) – Departamento de Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Sergipe, São Cristóvão, SE, 2023
dc.identifier.uri.fl_str_mv https://ri.ufs.br/jspui/handle/riufs/19330
identifier_str_mv Santos, Anny Rosielly Sousa. Uso de cannabis sativa no tratamento da doença de Parkinson. São Cristóvão, 2023. Monografia (graduação em Farmácia) – Departamento de Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Sergipe, São Cristóvão, SE, 2023
url https://ri.ufs.br/jspui/handle/riufs/19330
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.initials.fl_str_mv Universidade Federal de Sergipe (UFS)
dc.publisher.department.fl_str_mv DFA - Departamento de Farmácia – São Cristóvão - Presencial
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFS
instname:Universidade Federal de Sergipe (UFS)
instacron:UFS
instname_str Universidade Federal de Sergipe (UFS)
instacron_str UFS
institution UFS
reponame_str Repositório Institucional da UFS
collection Repositório Institucional da UFS
bitstream.url.fl_str_mv https://ri.ufs.br/jspui/bitstream/riufs/19330/1/license.txt
https://ri.ufs.br/jspui/bitstream/riufs/19330/2/Anny_Rosielly_Sousa_Santos.pdf
bitstream.checksum.fl_str_mv 098cbbf65c2c15e1fb2e49c5d306a44c
07c8edf96623d9b3b45dcc7e835bdd07
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)
repository.mail.fl_str_mv repositorio@academico.ufs.br
_version_ 1802110709051424768